Condition: Mesotheliomas Pleural · Malignant Pleural Mesothelioma · Sponsor: University Hospital, Lille
Pilot study of the feasibility of an innovative multimodal treatment combining intrapleural photodynamic therapy with videothoracoscopy followed by adjuvant immunotherapy with anti-PD-1 Nivolumab antibodies in patients with malignant pleural mesothelioma
This description comes directly from the study's public registry record.
Arnaud Scherpereel, MD,PhD · 320444998 · arnaud.scherpereel@chru-lille.fr
Eric Wasielewski, PhD · 3.20.44.56.12 · eric.wasielewski@chru-lille.fr
Always discuss trial participation with your own doctor first.
| Institut Coeur-Poumon, CHU | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04400539